SFARI held its fourteenth science meeting September 30–October 2, 2018. SFARI investigators, collaborators and foundation staff came together to discuss recent findings in autism genetics, molecular and system-level mechanisms, as well as clinical studies. The meeting featured keynote and session presentations, in addition to demo sessions of online platforms for visualizing and analyzing data sets relevant for autism research.
The SFARI Bridge to Independence (BTI) program engages talented early-career scientists from diverse and/or historically underrepresented backgrounds to pursue research in autism and facilitates their transition into independent faculty positions at research institutions within or outside the U.S.
The program is aimed at Ph.D. and/or M.D.-holding scientists from diverse and/or historically underrepresented groups in science who are currently in a non-independent, mentored training position at an institution within or outside the U.S. and who will be actively seeking and applying to tenure-track faculty positions between September 2024–May 2025. Independence Fellows are expected to apply, secure and transition to a tenure-track faculty position at a research institution within or outside the U.S. by the end of the 2025–2026 academic year. U.S. citizenship or permanent resident status is not required. The BTI Award program welcomes applications that span the breadth of science that SFARI supports, including genetics, molecular mechanisms, circuits and systems, and clinical science.
Independence Fellows will receive up to two (2) years of postdoctoral fellowship support during their job search, with an annual salary of $85,000 USD, fringe benefits, an annual resource and professional development allowance of $10,000 USD, and indirect costs (see our grant policies) followed by a commitment of $600,000 USD over three (3) years, including indirect costs (see our grant policies), activated upon assumption of a tenure-track research professorship. The fellows will form a learning community and engage in professional development activities throughout their transition to research independence.
On January 23, 2023, SFARI hosted an informational session on the 2023 Cross-Species Studies of ASD request for applications (RFA).
Karen Walton-Bowen joined Clinical Research Associates in 2014 to oversee clinical operations, biostatistical analysis and reporting, and the arbaclofen program. Walton-Bowen is an expert in clinical development across multiple therapeutic areas within the pharmaceutical and biotechnology industry, including gastrointestinal, neuroscience, respiratory, cardiovascular, lysosomal storage disorders, inflammation and pain control.
Whole-genome sequencing data for a total of 8,975 genomes from the Simons Simplex Collection are now available. This includes 2,174 genomes that have been available since August 2016 (and whose data have now been reprocessed using a new computational pipeline) in addition to 6,801 new genomes.
SFARI is pleased to announce that it has awarded 32 grants (19 Pilot Awards and 13 Research Awards) in response to the 2017 Pilot and Research Awards request for applications (RFA).
Yann Herault is a neurobiologist studying the pathophysiology of neurodevelopmental disorders at the French National Centre for Scientific Research (CNRS).
SFARI science staff will be presenting a number of posters about SFARI projects and resources at the International Society for Autism Research (INSAR) 2018 Annual Meeting in Rotterdam, Netherlands (May 9-12).
- Previous Page
- Viewing
- Next Page